Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

CRISPR gene editing stories

Oct 19, 2026

Peter Mac scientists develop CRISPR method to target gene fusions in one in five cancers

Scientists at Peter MacCallum Cancer Centre have developed a new CRISPR approach using PspCas13b nuclease to precisely target abnormal gene fusions, which occur in approximately 20% of cancers. The technique targets the unique molecular fingerprint created when two genes fuse together, potentially offering a new personalized treatment strategy.

Oct 19, 2026·1 source
00
Oct 6, 2026

Caribou Biosciences halts CAR-T programs and seeks strategic alternatives after failing to secure funding

Caribou Biosciences, a CRISPR biotech co-founded by Nobel laureate Jennifer Doudna, announced it will discontinue its two allogeneic CAR-T cell therapy programs and lay off staff after failing to secure funding for a pivotal lymphoma trial. The company's stock plunged 40% following the announcement as it explores strategic alternatives.

Oct 6, 2026·7 sources
00
Aug 2, 2026

CRISPR makes prostate cancer vulnerable to immunotherapy in mice

Scientists used CRISPR gene editing to make prostate cancer cells easier for the immune system to detect and destroy, dramatically improving immunotherapy effectiveness in mice.

Aug 2, 2026·1 source
00
Jul 2, 2026

FDA Expands Casgevy Gene Therapy Approval to Children as Young as Two with Sickle Cell Disease and Beta Thalassemia

The FDA has approved Vertex Pharmaceuticals' Casgevy (exagamglogene autotemcel) for patients aged two years and older with sickle cell disease and transfusion-dependent beta thalassemia, expanding from the previous minimum age of 12 years. The approval was granted under the agency's Commissioner's National Priority Voucher program.

Jul 2, 2026·3 sources
00
Apr 27, 2026

Intellia Reports Positive Pivotal Trial Results for CRISPR-Based Treatment of Rare Swelling Disease

Intellia Therapeutics announced that its CRISPR-based gene editing treatment reduced swelling attacks in a pivotal trial for hereditary angioedema, a rare genetic disease. The results advance the CRISPR field's one-and-done treatment approach toward potential regulatory approval.

Apr 27, 2026·1 source
00

Top claims

  • ▪The BCR-ABL1 gene fusion is present in nearly all chronic myeloid leukemia cases, while the EWSR1-FLI1 fusion occurs in over 85% of Ewing's sarcoma cases.
  • ▪Peter Mac researchers Dr. Wenxin Hu and Dr. Mohamad Fareh successfully targeted and silenced nine distinct gene fusions, including BCR-ABL1, in laboratory cell models.
  • ▪Researchers must verify that CRISPR-Cas13b can selectively target cancer cells without damaging healthy cells in complex living disease models.

Subtopics

Drug Policy, Pricing & Approval4Drug Approval and Clinical Trials3Gene therapy3Cancer & Oncology2Cancer immunotherapy2Biotechnology1Cancer Treatment & Therapies1Cancer treatment breakthroughs1Cancer Types1CAR T-cell therapy1Clinical trials1CRISPR1FDA drug approval1Immune system regulation1Lyme disease treatment1Oncology1Personalized medicine1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories